Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Pharm ; 654: 123963, 2024 Apr 10.
Artigo em Inglês | MEDLINE | ID: mdl-38430952

RESUMO

Inflammation in hair follicles will reduce the effectiveness of minoxidil (MXD) in the treatment of androgen alopecia (AGA) caused by elevated androgen levels. To target multiple physiological and pathological processes in AGA, a novel natural bioactive compound modified transfersomes (MXD-Rg3@TFs) was prepared to replace cholesterol that may disrupt hair growth, with ginsenosides Rg3 (Rg3) that have anti-inflammatory effects on AGA. The effects of MXD, Rg3 and their combination on AGA were evaluated using dihydrotestosterone (DHT) induced human dermal papilla cells (DPCs), and the results showed that the combination of MXD and Rg3 can significantly promote the proliferation, reduce the level of intracellular ROS and inflammatory factors, and inhibit the aging of DHT induced DPCs. Compared with cholesterol membrane transfersomes (MXD-Ch@TFs), MXD-Rg3@TFs has similar deformability, smaller particle size and better stability. MXD-Rg3@TFs has also significant advantages in shortening telogen phase and prolonging the growth period of hair follicles in C57BL/6 mice than MXD-Ch@TFs and commercial MXD tincture. The prominent ability of MXD-Rg3@TFs to inhibit the conversion of testosterone to DHT and reduce the level of inflammatory factors suggested that Rg3 and MXD in MXD-Rg3@TFs have synergistic effect on AGA therapy. MXD-Ch@TFs with no irritation to C57BL/6 mice skin is expected to reduce the dose of MXD and shorten the treatment time, which would undoubtedly provide a promising therapeutic option for treatment of AGA.


Assuntos
Ginsenosídeos , Minoxidil , Camundongos , Animais , Humanos , Minoxidil/farmacologia , Minoxidil/uso terapêutico , Ginsenosídeos/farmacologia , Androgênios/uso terapêutico , Camundongos Endogâmicos C57BL , Alopecia/tratamento farmacológico , Folículo Piloso , Di-Hidrotestosterona , Colesterol
2.
Artigo em Inglês | MEDLINE | ID: mdl-31323557

RESUMO

A metal organic framework (MOF)-polymer monolithic column was prepared by redox initiation using modified MOF and N-methylolacrylamide (NMA) as co-monomers. The obtained monolithic column was characterized by scanning electron microscopy (SEM) and nitrogen adsorption-desorption isotherm measurement. It was used as a solid phase extraction (SPE) absorbent for the online enrichment of ursolic acid (UA) by high performance liquid chromatography. The adsorption amount of UA on the monolith was compared with that of silica gel-C18 adsorbent and the monolith without MOF material. The MOF-polymer monolithic column showed high selectivity and good permeability. Under the optimum conditions for extraction and determination, the calibration equation was y = 79.854× + 0.1939; the linear range was 0.001-0.9 mg/mL; the linear regression coefficient was 0.9993; the limit of detection (LOD) and the limit of quantification (LOQ) were 0.17 µg/mL and 0.57 µg/mL, respectively; the inter-day and intra-day accuracies were <6.44%; the recovery was in the range of 86.52-105.26%. The MOF-polymer monolithic column was successfully used as SPE column for enrichment and determination of UA in Chinese herbal medicine.


Assuntos
Medicamentos de Ervas Chinesas/análise , Estruturas Metalorgânicas/química , Extração em Fase Sólida/métodos , Triterpenos/análise , Triterpenos/isolamento & purificação , Adsorção , Cromatografia Líquida de Alta Pressão , Limite de Detecção , Polímeros/química , Extração em Fase Sólida/instrumentação , Ácido Ursólico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...